Theme · live manifest · live theme JSON
Biotech '24: Pharma/Therapeutics
13 tickers · $37.01B total market cap
Group: Biotech
The current thesis for Biotech '24: Pharma/Therapeutics is bullish, driven by innovation in therapeutic solutions and strategic partnerships within the sector. The selected companies are well-positioned to capitalize on breakthroughs in drug development, particularly in areas like oncology and genetic disorders. Despite macroeconomic challenges, the sector benefits from robust R&D pipelines and favorable regulatory environments that support drug approvals.
Biotech '24: Pharma/Therapeutics tracks 13 publicly listed stocks in this theme. Sample tickers: ALT, ARQT, ARWR, AVXL, BCRX, BHVN, HALO, KNSA, KROS, KYMR, SPRY, TERN, and 1 more. Use the table below for the full list.
Thesis update: 2025-04-01
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc.ARWR | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -0.19% | -8.15% | 20.82% | 0.67% | $10.31B | 7.6923 |
Halozyme Therapeutics, Inc.HALO | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -10.49% | 10.62% | -7.82% | -3.10% | $8.15B | 7.6923 |
Kymera Therapeutics, Inc.KYMR | 04/30/2026 (BMO) | 04/30/2026 (BMO) | 0.74% | -0.98% | -10.77% | -3.18% | $6.43B | 7.6923 |
Kiniksa Pharmaceuticals, Ltd.KNSA | 04/28/2026 (BMO) | 04/28/2026 (BMO) | -9.77% | 21.51% | 1.99% | 0.66% | $4.01B | 7.6923 |
Arcutis Biotherapeutics, Inc.ARQT | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -0.15% | -11.78% | -10.38% | -5.61% | $2.44B | 7.6923 |
BioCryst Pharmaceuticals, Inc.BCRX | 05/06/2026 (BMO) | 05/06/2026 (BMO) | 15.89% | -1.44% | 3.20% | -1.46% | $1.84B | 7.6923 |
Viridian Therapeutics, Inc.VRDN | 05/05/2026 (AMC) | 05/05/2026 (AMC) | -0.37% | 24.68% | -36.18% | -8.90% | $1.36B | 7.6923 |
Biohaven Ltd.BHVN | 05/04/2026 (AMC) | 05/04/2026 (AMC) | -10.16% | 0.83% | -4.43% | -13.59% | $888.2M | 7.6923 |
ARS Pharmaceuticals, Inc.SPRY | 05/15/2026 (AMC) | 05/15/2026 (AMC) | -7.40% | -6.49% | -11.40% | -3.43% | $712.0M | 7.6923 |
Keros Therapeutics, Inc.KROS | 05/14/2026 (BMO) | 05/14/2026 (BMO) | -12.61% | -12.43% | 2.39% | -5.62% | $317.1M | 7.6923 |
Anavex Life Sciences Corp.AVXL | 02/09/2026 (BMO) | — | -3.41% | — | -32.58% | — | $247.4M | 7.6923 |
Altimmune, Inc.ALT | 05/13/2026 (AMC) | 05/13/2026 (AMC) | 1.00% | -5.19% | -14.69% | -6.16% | $241.8M | 7.6923 |
Terns Pharmaceuticals, Inc.TERN | 03/30/2026 (AMC) | — | -0.17% | — | 0.44% | — | $72.1M | 7.6923 |
| Average | -2.85% | 1.02% | -7.65% | -4.52% | $2.85B | 7.6923 | ||
| Median | -0.37% | -1.44% | -7.82% | -3.43% | $1.36B | 7.6923 | ||
| Std Dev | 7.25% | 12.08% | 14.45% | 3.99% | $3.25B | 0.0% | ||
| Min | -12.61% | -12.43% | -36.18% | -13.59% | $72.1M | 7.6923 | ||
| Max | 15.89% | 24.68% | 20.82% | 0.67% | $10.31B | 7.6923 | ||
| % Positive Tickers | 23.08% | 36.36% | 38.46% | 18.18% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.